Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

PRVL

Prevail Therapeutics (PRVL)

Prevail Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PRVL
FechaHoraFuenteTítuloSímboloCompañía
16/02/202115:43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRVLPrevail Therapeutics Inc
01/02/202105:41Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:PRVLPrevail Therapeutics Inc
29/01/202115:16Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRVLPrevail Therapeutics Inc
29/01/202105:13Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRVLPrevail Therapeutics Inc
27/01/202105:12Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRVLPrevail Therapeutics Inc
26/01/202116:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
22/01/202115:39Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRVLPrevail Therapeutics Inc
22/01/202108:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRVLPrevail Therapeutics Inc
22/01/202108:03Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:PRVLPrevail Therapeutics Inc
22/01/202107:55PR Newswire (US)Lilly Completes Acquisition of Prevail TherapeuticsNASDAQ:PRVLPrevail Therapeutics Inc
20/01/202106:01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PRVLPrevail Therapeutics Inc
20/01/202105:44Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PRVLPrevail Therapeutics Inc
22/12/202007:50Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PRVLPrevail Therapeutics Inc
22/12/202007:34Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:PRVLPrevail Therapeutics Inc
22/12/202006:08Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:PRVLPrevail Therapeutics Inc
15/12/202016:05Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:PRVLPrevail Therapeutics Inc
15/12/202006:35Dow Jones NewsLilly Raises 2020 Guidance, Sets 2021 OutlookNASDAQ:PRVLPrevail Therapeutics Inc
15/12/202006:17Dow Jones NewsLilly to Buy Prevail Therapeutics for Up to $1.04 BillionNASDAQ:PRVLPrevail Therapeutics Inc
15/12/202005:39Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:PRVLPrevail Therapeutics Inc
15/12/202005:15PR Newswire (US)Lilly Announces Agreement to Acquire Prevail TherapeuticsNASDAQ:PRVLPrevail Therapeutics Inc
11/12/202006:00GlobeNewswire Inc.Prevail Therapeutics Announces First Patient Dosed in Phase 1/2 PROCLAIM Clinical Trial Evaluating PR006 for the Treatment of...NASDAQ:PRVLPrevail Therapeutics Inc
30/11/202006:00GlobeNewswire Inc.Prevail Therapeutics Receives European Commission Orphan Designation for PR006 for the Treatment of Frontotemporal DementiaNASDAQ:PRVLPrevail Therapeutics Inc
18/11/202018:01GlobeNewswire Inc.Prevail Therapeutics Granted Composition of Matter Patent for Experimental Gene Therapy Program PR001NASDAQ:PRVLPrevail Therapeutics Inc
13/11/202006:21Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PRVLPrevail Therapeutics Inc
13/11/202006:00GlobeNewswire Inc.Prevail Therapeutics Reports Third Quarter 2020 Financial Results and Business HighlightsNASDAQ:PRVLPrevail Therapeutics Inc
10/11/202006:00GlobeNewswire Inc.Prevail Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:PRVLPrevail Therapeutics Inc
02/11/202006:00GlobeNewswire Inc.Prevail Therapeutics Announces Decisive Victory in Arbitration Brought by Alector against Prevail’s CEONASDAQ:PRVLPrevail Therapeutics Inc
27/10/202006:00GlobeNewswire Inc.Prevail Therapeutics Receives U.S. FDA Fast Track Designation for PR001 for the Treatment of Neuronopathic Gaucher DiseaseNASDAQ:PRVLPrevail Therapeutics Inc
18/09/202014:04GlobeNewswire Inc.Prevail Therapeutics to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech SummitNASDAQ:PRVLPrevail Therapeutics Inc
11/09/202007:29Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PRVLPrevail Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PRVL